Postoperative external beam radiotherapy for resected pancreatic adenocarcinoma: Impact of chemotherapy on local control and survival

Anticancer Research

Volumn 30, Issue 7, 2010, Pages 2959-2967

  Ogawa, Kazuhiko ^a   Shibuya, Hitoshi ^b   Uchida, Nobue ^c   Onishi, Hiroshi ^d   Okuno, Yoshishige ^e   Myojin, Miyako ^f   Kobayashi, Masao ^g   Ogawa, Yoshihiro ^h   Kanesaka, Naoto ⁱ   Shibuya, Keiko ^j   Tokumaru, Sunao ^k   Sasamoto, Ryuta ^l   Karasawa, Katsuyuki ^m   Nemoto, Kenji ⁿ   Nishimura, Yasumasa ^o  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c SHIMANE UNIVERSITY   (Japan)

^d UNIVERSITY OF YAMANASHI   (Japan)

^e KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^f HOKKAIDO CANCER CENTER   (Japan)

^g JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^h TOHOKU UNIVERSITY   (Japan)

ⁱ TOKYO MEDICAL UNIVERSITY   (Japan)

^j KYOTO UNIVERSITY   (Japan)

^k SAGA UNIVERSITY   (Japan)

^l NIIGATA UNIVERSITY   (Japan)

^m TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

ⁿ YAMAGATA UNIVERSITY   (Japan)

^o KINKI UNIVERSITY   (Japan)

more..

Author keywords

Chemotherapy; Pancreatic neoplasms; Postoperative; Radiotherapy

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CA 19-9 ANTIGEN; CISPLATIN; FLUOROURACIL; GEMCITABINE; TEGAFUR; UFT; URACIL;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER GRADING; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; INFORMATION PROCESSING; MALE; MEDICAL RECORD REVIEW; METASTASIS; MORBIDITY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL TIME; TREATMENT DURATION; TREATMENT FAILURE; TUMOR VOLUME; UNIVARIATE ANALYSIS;

ADENOCARCINOMA; AGED; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; PANCREATIC NEOPLASMS; POSTOPERATIVE CARE; RETROSPECTIVE STUDIES;

EID: 77955784297     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Jemal A, Siegel R, Siegel R, Ward E, Hao Y, Xu J and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin 55: 71-96, 2008.
2. Gudjonsson B: Cancer of the pancreas. 50 Years of surgery. Cancer 60: 2284-303, 1987.
3. Tepper J, Nardi G and Sutt H: Carcinoma of the pancreas: review of MGH experience from 1963 to 1973. Analysis of surgical failure and implications for radiation therapy. Cancer 37: 1519-24, 1976.
4. Rich TA, Evans DB, Curley SA and Ajani JA: Adjuvant radiotherapy and chemotherapy for biliary and pancreatic cancer. Ann Oncol 5 Suppl 3: 75-80, 1994. (Pubitemid 24094629)
5. Griffin JF, Smalley SR, Paradelo JC, Reymond RD, Hassanein RE and Evans RG: Patterns of failure after curative resection of pancreatic carcinoma. Cancer 66: 56-61, 1990. (Pubitemid 20197085)
6. h edition. Philadelphia, Lippincott, pp. 1054-1087, 1997.
7. Kasler MH and Ellenberg SS: Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 120: 899-903, 1985.
8. Klinkenbijl JH, Jeekel J, Sahmoud T, van Pel R, Couvreur ML, Veenhof CH, Arnaud JP, Gonzalez DG, de Wit LT, Hennipman A and Wils J: Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230: 776-782, 1999.
9. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H, Beger H, Fernandez-Cruz L, Dervenis C, Lacaine F, Falconi M, Pederzoli P, Pap A, Spooner D, Kerr DJ and Büchler MW: European Study Group for Pancreatic Cancer: A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350: 1200-1210, 2004.
10. Stocken DD, Büchler MW, Dervenis C, Bassi C, Jeekel H, Klinkenbijl JH, Bakkevold KE, Takada T, Amano H and Neoptolemos JP: Pancreatic Cancer Meta-analysis Group: Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer. Br J Cancer 92: 1372-1381, 2005.
11. Herman JM, Swartz MJ, Hsu CC, Winter J, Pawlik TM, Sugar E, Robinson R, Laheru DA, Jaffee E, Hruban RH, Campbell KA, Wolfgang CL, Asrari F, Donehower R, Hidalgo M, Diaz LA Jr., Yeo C, Cameron JL, Schulick RD and Abrams R: Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 26: 3503-3510, 2008.
12. Corsini MM, Miller RC, Haddock MG, Donohue JH, Farnell MB, Nagorney DM, Jatoi A, McWilliams RR, Kim GP, Bhatia S, Iott MJ and Gunderson LL: Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol. 26: 3511-3516, 2008.
13. Ogawa K, Ito Y, Karasawa K, Ogawa Y, Onishi H, Kazumoto T, Shibuya K, Shibuya H, Okuno Y, Nishino S, Ogo E, Uchida N, Karasawa K, Nemoto K and Nishimura Y: Patterns of Radiotherapy Practice for Pancreatic Cancer in Japan: Results of the Japanese Radiation Oncology Study Group (JROSG) Survey. Int J Radiat Oncol Biol Phys 77: 743-750, 2010.
14. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Ijngu K, Onishi H, Aoki S, Wada H, Kokubo M, Etoh H, Kazumoto T, Takayama M, Negoro Y, Nemoto K and Nishimura Y: Intraoperative radiotherapy for resected pancreatic cancer: A multi-institutional retrospective analysis of 210 patients. Int J Radiat Oncol Biol Phys, 2009, in press.
15. Ogawa K, Karasawa K, Ito Y, Ogawa Y, Ijngu K, Onishi H, Aoki S, Wada H, Kokubo M, Ogo E, Etoh H, Kazumoto T, Takayama M, Nemoto K and Nishimura Y: Intraoperative radiotherapy for unresectable pancreatic cancer: A multi-institutional retrospective analysis of 144 patients. Int J Radiat Oncol Biol Phys 77: 734-742, 2010.
16. th edition. New York, Wiley, 2002.
17. Kaplan EL and Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53: 457-81, 1958.
18. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-170, 1966.
19. Cox DR: Regression models and life tables. J R Stat Soc 34: 187-220, 1972.
20. Whittington R, Bryer MP, Haller DG, Solin LJ and Rosato EF: Adjuvant therapy of resected adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys 21: 1137-1143, 1991.
21. Paulino AC: Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure. Am J Clin Oncol 22: 489-494, 1999.
22. Bosset JF, Pavy JJ, Gillet M, Mantion G, Pelissier E and Schraub S: Conventional external irradiation alone as adjuvant treatment in resectable pancreatic cancer: results of a prospective study. Radiother Oncol 24: 191-194, 1992.
23. NCCN Clinical Practice Guidelines in Oncology TM: Pancratic adenocarcinoma. V.I.2008. http://www.nccn.org/
24. Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH and Lillemoe KD: Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators. J Gastrointest Surg 4: 567-579, 2000.
25. Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen Q and Janjan NA: Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-fluorouracil-based chemoradiation in locally advanced pancreatic cancer? Int J Radiat Oncol Biol Phys 52: 1293-1302, 2002.
26. Zacharias T, Jaeck D, Oussoultzoglou E, Neuville A and Bachellier P: Impact of lymph node involvement on long-term survival after RO pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas. J Gastrointest Surg 11: 350-356, 2007.
27. Howard TJ, Krug JE, Yu J, Zyromski NJ, Schmidt CM, Jacobson LE, Madura JA, Wiebke EA and Lillemoe KD: A margin-negative RO resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 10: 1338-1345, 2006.
28. Reni M, Panucci MG, Ferreri AJ, Balzano G, Passoni P, Cattaneo GM, Cordio S, Scaglietti U, Zerbi A, Ceresoli GL, Fiorino C, Calandrino R, Staudacher C, Villa E and Di Carlo V: Effect on local control and survival of electron beam intraoperative irradiation for resectable pancreatic adenocarcinoma. Int J Radiat Oncol Biol Phys 50: 651-658, 2001.
29. Alfieri S, Morganti AG, Di Giorgio A, Valentini V, Bossola M, Tradelia L, Cellini N and Doglietto GB: Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: a multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer. Arch Surg 136: 343-347, 2001. (Pubitemid 32204974)
30. Pisters PW, Wolff RA, Janjan NA, Cleary KR, Charnsangavej C, Crane CN, Lenzi R, Vauthey JN, Lee JE, Abbruzzese JL and Evans DB: Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol 20: 2537-2544, 2002.
31. Schwarz RE, Smith DD, Keny H, Iklé DN, Shibata SI, Chu DZ and Pezner RD: Impact of intraoperative radiation on postoperative and disease-specific outcome after pancreatoduodenectomy for adenocarcinoma: a propensity score analysis. Am J Clin Oncol 26: 16-21, 2003. (Pubitemid 36205891)
32. Moertel CG, Reitemeier RJ and Hahn RG: Mitomycin C therapy in advanced gastrointestinal cancer. JAMA 204: 1045-1048, 1968.
33. Buroker T, Kim PN, Groppe C, McCracken J, O'Bryan R, Panettiere F, Costanzi J, Bottomley R, King GW, Bonnet J, Thigpen T, Whitecar J, Haas C, Vaitkevicius VK, Hoogstraten B and Heilbrun L: 5-FU infusion with mitomycin-C vs. 5-FU infusion with methyl-CCNU in the treatment of advanced upper gastrointestinal cancer: a Southwest Oncology Group Study. Cancer 44: 1215-1221, 1979.
34. Burris HA 3rd, Moore MJ, Andersen J, Green MR, Rothenberg ML, Modiano MR, Cripps MC, Portenoy RK, Storniolo AM, Tarassoff P, Nelson R, Dorr FA, Stephens CD and Von Hoff DD: Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol 15: 2403-2413, 1997.
35. Ikeda M, Okusaka T, Ito Y, Ueno H, Morizane C, Furuse J, Ishii H, Kawashima M, Kagami Y and Ikeda H: A phase I trial of S-1 with concurrent radiotherapy for locally advanced pancreatic cancer. Br J Cancer 96: 1650-1655, 2007. (Pubitemid 46847209)
36. Childs HA 3rd, Spencer SA, Raben D, Bonner JA, Newsome J and Robert F: A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer. Int J Radiat Oncol Biol Phys 47: 939-944, 2000. (Pubitemid 30345591)
37. Varadhachary GR, Wolff RA, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Abdalla E, Wang H, Staerkel GA, Lee JH, Ross WA, Tamm EP, Bhosale PR, Krishnan S, Das P, Ho L, Xiong H, Abbruzzese JL and Evans DB: Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26: 3487-3495, 2008.
38. Evans DB, Varadhachary GR, Crane CH, Sun CC, Lee JE, Pisters PW, Vauthey JN, Wang H, Cleary KR, Staerkel GA, Charnsangavej C, Lano EA, Ho L, Lenzi R, Abbruzzese JL and Wolff RA: Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 26: 3496-3502, 2008.
39. Valentini V, Morganti AG, Macchia G, Mantini G, Mattiucci GC, Brizi MG, Alfieri S, Bossola M, Pacelli F, Sofo L, Doglietto G and Cellini N: Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. Int J Radiat Oncol Biol Phys 70: 1094-1099, 2008.
40. Stessin AM, Meyer JE and Sherr DL: Neoadjuvant radiation is associated with improved survival in patients with resectable pancreatic cancer: an analysis of data from the surveillance, epidemiology, and end results (SEER) registry. Int J Radiat Oncol Biol Phys 72: 1128-1133, 2008.